ST
Suzhou Tianma Pharma Group Tianji Bio-Pharmaceutical Co., Ltd.
CDMO · Suzhou, China
Overview
Suzhou Tianji Biopharma, founded in 2000, is the flagship company of Suzhou Tianma Pharma Group. It makes peptide and small-molecule APIs, lyophilized and small-volume injectables and topical products, and offers custom peptide development and CRO, CMO and CDMO services. It holds active US Type II DMFs for Degarelix, Difelikefalin, Linaclotide, Liraglutide, Octreotide, Semaglutide, Thymalfasin, Tirzepatide. Its site says some products are approved by overseas regulators but does not name them, so regulator GMP evidence was not confirmed.
Capabilities
- Peptide APIs incl. GLP-1s
- Custom peptide synthesis
- CRO/CDMO services
- Lyophilized injectables
- Regulatory filing support
Quality signals
| GMP evidence | Not found |
|---|---|
| Certificates of analysis | Not found |
| Third-party testing | Not found |
| ISO certification | Not found |
| Makes own product | Yes, in-house production |